Navigation Links
China Yingxia International, Inc. Announces $2 Million Share Repurchase Program
Date:10/9/2008

HARBIN, China, Oct. 9 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food products, dietary supplements, and raw cactus plants in the People's Republic of China ("PRC"), today announced that the Board of Directors of the Company has approved and authorized a share repurchase program for up to $2 million of its common stock.

China Yingxia will repurchase shares on the open market or through privately negotiated transactions through September 30, 2009, in compliance with the rules and regulations of the U.S. Securities and Exchange Commission. The final number of shares repurchased and the timing of the purchases will depend on market conditions, share price, applicable legal requirements, and other factors deemed appropriate by the Board of Directors. The repurchase program may be discontinued or expanded by the Board of Directors in the future.

The repurchases will be funded with available cash on hand. As of August 14, 2008, the Company had 44.5 million common shares outstanding and approximately 10.9 million freely traded shares. Any shares repurchased by the Company in this program will reduce the number common shares outstanding.

"Our strong balance sheet provides us with the opportunity to return value to our shareholders through a stock repurchase program without impacting our ability to engage in new investments for future growth. We have recently completed the most capital intensive phase of our growth plan by increasing production capacity. Now we will focus on expanding our franchisee-based distribution network and product offerings," said Ms. Yinxia Jiao, CEO and Chairwoman of China Yingxia. "We expect our cash position to further improve in the near future due to profitable operations, reduction in inventory and collection of receivables toward the end of the year. While our third quarter financial results have not been finalized, initial feedback from our sales department is positive. We remain confident in our competitive position in China's growing health and nutritional foods market," she added.

About China Yingxia International, Inc.

China Yingxia International, Inc., through its 100%-owned subsidiary, Harbin Yingxia Industrial Group Co., Ltd. ('Yingxia'), is primarily engaged in the development, production and sales of health food products in China. Yingxia is located in the Province of Heilongjiang, Peoples Republic of China. Yingxia's products include soybean-based foods and drinks, longgu golden millet enriched products, organic rice products, raw cacti, cactus and other herbal-based supplements, cosmetics, personal care products, and Nestle products.

Safe Harbor Statement

The statements contained herein that are not historical facts are "forward-looking statements" within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by, among other things, the use of forward-looking terminology such as "believes," "expects," "may," "will," "should," or "anticipates," "expect" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy that involve risks and uncertainties. In particular, our statements regarding the potential growth of the markets or forecasting financial results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including but not limited to, general economic conditions and regulatory developments, not within our control. The factors discussed herein and expressed from time to time in our filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed or implied by such statements. The forward-looking statements are made only as of the date of this filing, and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

For more information, please contact:

Company Contact:

Mr. Ren Hu

Chief Financial Officer

China Yingxia International, Inc

Tel: +1-201-887-0415

Email: arenhu@gmail.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915

Email: crocker.coulson@ccgir.com

Web: http://www.ccgir.com


'/>"/>
SOURCE China Yingxia International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused ... announced today that Dr. Miriam Kidron , ... titled, "Oral Insulin for Diabetes Treatment: Bypassing the ... and Peptide Therapeutics (OPT) Boston Conference in ...
(Date:3/22/2017)...   Boston Biomedical , an industry leader in ... cancer stemness pathways, today announced its Board of Directors ... Executive Officer, effective April 24, 2017. ... M.D., FACP, who has led Boston Biomedical since he ... Boston Biomedical has grown from a "garage startup" without ...
(Date:3/22/2017)... ... 21, 2017 , ... Benchworks CEO Thad L. Bench Sr. will ... March 23-24 in San Diego. The event is a gathering of executive leadership from ... Vice President Christian Meyer will also participate in the forum. Participants will discuss the ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Society for Immunotherapy ... as outlined in the Administration’s recently published fiscal year 2018 budget request. , ... of Health (NIH) by $5.8 billion or roughly 20% of its total budget. If ...
Breaking Biology Technology:
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
(Date:3/2/2017)... Who risk to be deprived of its imprint in ... https://www.reportbuyer.com/product/4313699/ WILL APPLE AND SAMSUNG CONFRONT EACH ... using capacitive technology represent a fast growing market, especially ... increase of 360% of the number of fingerprint sensor ... market between 2014 and 2017 (source : N+1 Singer, ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
Breaking Biology News(10 mins):